Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in peritoneal dialysis patients with uremia and heart failure
ChiCTR2100043953Phase 4Recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sacubitril + valsartan in heart failure (HF), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: NT-proBNP, Echocardiogram and 4 more. Started Mar 2021; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2100043953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043953.